Marché européen des diagnostics au point de service – Tendances et prévisions du secteur jusqu'en 2029

Analyse et perspectives du marché : Marché européen des diagnostics au point de service

Le marché du diagnostic au point de service devrait connaître une croissance de 10,22 % au cours de la période de prévision de 2022 à 2029. Le rapport de recherche sur le marché du diagnostic au point de service de Data Bridge fournit une analyse et des informations sur les différents facteurs qui devraient prévaloir tout au long de la période de prévision tout en fournissant leurs impacts sur la croissance du marché. L'augmentation de l'incidence des maladies ciblées accélère la croissance du marché du diagnostic au point de service.

Les diagnostics au point de service sont des approches utilisées pour identifier les infections de manière précoce et rapide. Ces procédures sont extrêmement sensibles, rentables et produisent des résultats dans un délai court. Ces méthodes de test sont utilisées par les écoles, les médecins, les patients externes, les laboratoires cliniques et les soins à domicile .

Les principaux facteurs qui devraient stimuler la croissance du marché du diagnostic au point de service au cours de la période de prévision sont l'augmentation du besoin de soins de santé à domicile qui a poussé les fabricants. En outre, l'importance croissante du diagnostic au point de service dans la surveillance environnementale et la santé publique devrait encore propulser la croissance du marché du diagnostic au point de service. De plus, les développements technologiques et les lancements de nouveaux produits devraient encore amortir la croissance du marché du diagnostic au point de service. D'autre part, la pression sur les dépenses due aux réductions de remboursement et aux restrictions budgétaires devrait encore entraver la croissance du marché du diagnostic au point de service au cours de la période envisagée.

En outre, l’augmentation du nombre d’approbations réglementaires pour les techniques modernes d’immuno-essais offrira de nouvelles opportunités potentielles de croissance pour le marché des diagnostics au point d’intervention dans les années à venir. Cependant, les politiques d’accord chronophages rallongent considérablement la période de développement pour les lancements de produits, ce qui pourrait encore remettre en cause la croissance du marché des diagnostics au point d’intervention dans un avenir proche.

This point-of-care diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the point-of-care diagnostics market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you take an informed market decision to achieve market growth. 

Europe Point-Of-Care Diagnostics Market Scope and Market Size

The point-of-care diagnostics market is segmented on the basis of product, platform, prescription and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications. 

• On the basis of product, the point-of-care diagnostics market is segmented into glucose monitoring products, cardio metabolic, infectious disease, coagulation, pregnancy and fertility, tumor or cancer marker, urinalysis, cholesterol, haematology, drugs-of-abuse, fecal occult and others. Glucose monitoring products is further sub segmented into strips, meters and lancets and lancing device. Cardiometabolic is further sub segmented into cardiac marker, blood gas or electrolytes and HBA1C. Infectious disease is further sub segmented into influenza, HIV, hepatitis C, sexually transmitted disease (STD), healthcare-associated infection (HAI), respiratory infection, tropical disease and other infectious disease. Coagulation is further sub segmented into PT or INR and activated clotting time (ACT or APTT). Pregnancy and fertility is further sub segmented into pregnancy test and fertility test.
• On the basis of platform, the point-of-care diagnostics market is segmented into lateral flow assays (immunochromatography tests), dipsticks, microfluidics, molecular diagnostics and immunoassays.
• On the basis of prescription, the point-of-care diagnostics market is segmented into prescription-based testing and OTC testing.
• On the basis of end user, the point-of-care diagnostics market is segmented into clinical laboratories, outpatient healthcare and ambulatory care settings, hospitals or critical care centers, home care, research laboratories and other.

Point-Of-Care Diagnostics Market Country Level Analysis

The point-of-care diagnostics market is analysed, and market size insights and trends are provided by country, product, platform, prescription and end user as referenced above.      

The countries covered in the point-of-care diagnostics market report are the Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.

France is projected to observe significant amount of growth in the point-of-care diagnostics market due to the rise in the prevalence of unhealthy lifestyles and growing number of chronic diseases. Moreover, the augmented FDA approvals and government laws that are connected to healthcare advancement which is further anticipated to propel the growth of the point-of-care diagnostics market in the region in the coming years.

The country section of the point-of-care diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as consumption volumes, production sites, and volumes, import-export analysis, price trend analysis, cost of raw materials, downstream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The point-of-care diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the point-of-care diagnostics market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the point-of-care diagnostics market. The data is available for the historic period 2010-2020.

Competitive Landscape and Point-Of-Care Diagnostics Market Share Analysis

The North America point-of-care diagnostics market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the point-of-care diagnostics market.

Français Les principaux acteurs couverts dans le rapport sur le marché du diagnostic au point de service sont Abbott, Danaher, BD, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Instrumentation Laboratory SpA – Werfen, bioMérieux SA, Trividia Health, Inc., QIAGEN, Sekisui Diagnostics, Siemens Healthcare GmbH, Quidel Corporation, Spectral Medical Inc., Abaxis, Nova Biomedical, Trinity Biotech, Alfa Scientific Designs, Inc., ?PTS Diagnostics, Bio-Rad Laboratories, Inc. et Medica Corporation, entre autres.

SKU-1906